JP2000290184A5 - - Google Patents

Download PDF

Info

Publication number
JP2000290184A5
JP2000290184A5 JP1999095033A JP9503399A JP2000290184A5 JP 2000290184 A5 JP2000290184 A5 JP 2000290184A5 JP 1999095033 A JP1999095033 A JP 1999095033A JP 9503399 A JP9503399 A JP 9503399A JP 2000290184 A5 JP2000290184 A5 JP 2000290184A5
Authority
JP
Japan
Prior art keywords
group
substituted
unsubstituted
represented
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1999095033A
Other languages
English (en)
Other versions
JP2000290184A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP11095033A priority Critical patent/JP2000290184A/ja
Priority claimed from JP11095033A external-priority patent/JP2000290184A/ja
Publication of JP2000290184A publication Critical patent/JP2000290184A/ja
Publication of JP2000290184A5 publication Critical patent/JP2000290184A5/ja
Pending legal-status Critical Current

Links

Description

(式中、R及びRは、同一または異なって、水素、ヒドロキシルメチル基、メルカプトメチル基、置換もしくは非置換のアルコキシメチル基、置換もしくは非置換のアルキルチオメチル基、置換もしくは非置換のアルケニルオキシメチル基、または置換もしくは非置換のアルケニルチオメチル基を表し、Rは、アルキル基を表す)で表される化合物(K252a誘導体)[以下、一般式(I)で表される化合物を化合物(I)という。他の式番号の化合物についても同様である]は、アルツハイマー病などの神経変性疾患の治療に有益な化合物である[J.Med.Chem.,40,1863−1869(1997)、特表平6−504731、WO96/13506]。
JP11095033A 1999-04-01 1999-04-01 経鼻投与製剤 Pending JP2000290184A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11095033A JP2000290184A (ja) 1999-04-01 1999-04-01 経鼻投与製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11095033A JP2000290184A (ja) 1999-04-01 1999-04-01 経鼻投与製剤

Publications (2)

Publication Number Publication Date
JP2000290184A JP2000290184A (ja) 2000-10-17
JP2000290184A5 true JP2000290184A5 (ja) 2006-05-18

Family

ID=14126786

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11095033A Pending JP2000290184A (ja) 1999-04-01 1999-04-01 経鼻投与製剤

Country Status (1)

Country Link
JP (1) JP2000290184A (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117645D0 (en) * 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923986A (en) * 1987-03-09 1990-05-08 Kyowa Hakko Kogyo Co., Ltd. Derivatives of physiologically active substance K-252
GB8712176D0 (en) * 1987-05-22 1987-06-24 Cosmas Damian Ltd Drug delivery system
JPH07242550A (ja) * 1994-03-02 1995-09-19 Teijin Ltd 二次性副甲状腺機能亢進症治療剤
BR9710693A (pt) * 1996-06-25 2000-01-11 Cephalon Inc Uso de um derivado de k-252a para o tratamento do nervo central ou periférico e super produção de citoquinona.

Similar Documents

Publication Publication Date Title
BR0000968A (pt) ácidos oxâmicos contendo ciano e seus derivados como ligantes de receptores da tiróide
WO2005095384A8 (en) Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists
PT1063228E (pt) Derivados de cicloalcenos processo para a sua preparacao e utilizacao
JP2002527414A5 (ja)
PT1043310E (pt) Derivados de bifenilamidina
BR0311338A (pt) Derivados de n-acilaminobenzeno como inibidores seletivos da monoamina oxidade b
ATE231850T1 (de) Isochroman verbindungen und verfahren zu deren produktion
NO932520D0 (no) Preparat for helbredelse av sykdommen sjoegren's syndrom
DE60025616D1 (de) Isoindolderivate
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
FI942976A0 (fi) 5-amino-8-metyyli-7-pyrrolidinyylikinoliini-3-karboksyylihappojohdannaiset
WO2002036118A3 (en) Heterocyclic derivatives useful as pharmaceutical agents
ATE284684T1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
CY1110622T1 (el) Νεα παραγωγα 3-φαινυλοπροπιονικου οξεος για την αντιμετωπιση του διαβητη
NO20080860L (no) Substituert propanamidderivat og farmasoytisk preparat som inneholder dette
DE69600272D1 (de) Chinolin-4-carbonylguanidin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DK0556813T3 (da) Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler
EP1493441A4 (en) THERAPEUTIC AGENT FOR FOOD DISEASES IN THE STOMACH
JP2003012516A5 (ja)
JPH10152487A5 (ja)
BR0315762A (pt) Utilização de derivados de ácidos piperazino-sulfónicos como antagonistas ccr1 para o tratamento de fibrose, doença de alzheimer e outras doenças
JP2001288106A5 (ja)
ATE243219T1 (de) 9a, 11b-dehydro derivative von 9-oxime-3-keto-6-0-methylerythromycin
JP2007518681A5 (ja)
EP1650191A4 (en) THERAPEUTIC AGENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND METHOD OF TREATMENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING THE SAME